Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16321574 | 0.90 | ALDH1A1 (0.60) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL9472521 | 0.89 | ALDH1A1 (0.58) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL15836552 | 0.89 | ALDH1A1 (0.58) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL16808763 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL12644301 | 0.87 | ALDH1A1 (0.61) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL17410249 | 0.86 | TSHR (0.59) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL12390924 | 0.86 | ALDH1A1 (0.56) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL9344957 | 0.86 | TSHR (0.59) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL92203 | 0.85 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL14037690 | 0.85 | ALDH1A1 (0.65) | ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230134280-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-04 | — | — | US | disclosed |
| US-20160152739-A1 | ISOCYANATE/SILOXANE POLYETHER COMPOSITION | EVONIK DEGUSSA GMBH (DE) | 2016-06-02 | — | — | US | disclosed |
| WO-2014202339-A1 | ISOCYANATE/SILOXANE POLYETHER COMPOSITION | EVONIK INDUSTRIES AG (DE) | 2014-12-24 | — | — | WO | disclosed |
| US-20130030071-A1 | END-FUNCTIONALIZED POLYMERS | BASF SE (DE) | 2013-01-31 | — | — | US | disclosed |
| US-7897688-B2 | Amino group-terminal viscosifiers, resultant products and uses thereof | SIKA TECHNOLOGY AG (CH) | 2011-03-01 | — | — | US | disclosed |
| US-7897688-B2 | Amino group-terminal viscosifiers, resultant products and uses thereof | SIKA TECHNOLOGY AG (CH) | 2011-03-01 | — | — | US | disclosed |
| US-20090247708-A1 | Amino group-terminal viscosifiers, resultant products and uses thereof | SIKA TECHNOLOGY AG (CH) | 2009-10-01 | — | — | US | disclosed |
| US-20090247708-A1 | Amino group-terminal viscosifiers, resultant products and uses thereof | SIKA TECHNOLOGY AG (CH) | 2009-10-01 | — | — | US | disclosed |
| EP-1919960-B1 | AMINO GROUP-TERMINAL VISCOSIFIERS, RESULTANT PRODUCTS AND USES THEREOF | SIKA TECHNOLOGY AG (CH) | 2009-05-27 | — | — | EP | disclosed |
| WO-2007020266-A1 | AMINO GROUP-TERMINAL VISCOSIFIERS, RESULTANT PRODUCTS AND USES THEREOF | SIKA TECHNOLOGY AG (CH) | 2007-02-22 | — | — | WO | disclosed |
| EP-1754721-A1 | Amino groups terminated tougheners, their derivatives and their use | Sika Technology AG (CH) | 2007-02-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247708-A1 | Amino group-terminal viscosifiers, resultant products and uses thereof | GFER, MMAB, AGER | ALDH1A1 202/4885CYP3A4 2385/4885TSHR 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.